MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Making Tumor Treatment Less Complicated

Roche and GE Healthcare are releasing, the Navify Tumor Board, a solution that allows healthcare professionals to have complete patient diagnostic information in one location.

Roche and GE Healthcare are releasing the first product from their oncology collaboration.

The duo’s product, the Navify Tumor Board allows teams who determine treatment plans for cancer patients - to have a more comprehensive view of each patient in one place.

Here is a bit more of how the solution works. The integration of GE Healthcare’s medical image viewer into Navify Tumor Board 2.0 enables radiologists to upload their patient records to the same dashboard where patient files from other disciplines in the cancer care team are stored.

Having complete patient diagnostic information in one location helps specialists use the limited time they have during tumor boards to review all relevant files quickly and align on the best possible treatment plan for each cancer patient.

“We are delighted to announce the first major milestone of our ongoing collaboration with Roche, as we work together to enable precision healthcare. Workflows around tumor boards can be inefficient, and we hope this single, holistic dashboard - including patient data and images - will enable oncology teams to align more quickly on the most optimal diagnosis and treatment plan for the benefit of each patient,” said Tom McGuinness, President and CEO, GE Healthcare Imaging.

The solution will initially be available in the U.S. and Canada with additional markets to follow. Roche and GE Healthcare began their collaboration in January of 2018.

 

Filed Under
500 characters remaining